Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Big pharma leads the way in stock market resurgence
EP Vantage
Wed, 07/7/21 - 10:49 am
Tags:
Big Pharma, pharma stocks, Acadia Pharmaceuticals, AstraZeneca, Biogen, Eli Lilly, GSK, Merck, Moderna Therapeutics, Novartis, Sanofi, Provention Bio
Calls grow for an investigation into FDA approval of Biogen’s Alzheimer’s drug
Stat
Wed, 06/30/21 - 10:20 pm
Tags:
FDA, Biogen, Aduhelm, drug approvals
ICER finds Biogen’s new exorbitantly priced Alzheimer’s drug doesn’t match even an optimistic view of potential clinical benefits
Endpoints
Wed, 06/30/21 - 11:04 am
Tags:
Biogen, ICER, Aduhelm, Alzheimer's disease, drug pricing
Promised EAP Date Approaching for Biogen's Highly Publicized ALS Drug
BioSpace
Wed, 06/30/21 - 12:13 am
Tags:
Biogen, tofersen, ALS
FDA and Biogen discussed Aduhelm's accelerated approval as early as 2019 — report
Endpoints
Tue, 06/29/21 - 11:05 am
Tags:
FDA, Biogen, Aduhelm, accelerated approvals, Alzheimer's disease
Biopharma M&A set for a strong H2 despite political noise—and Biogen and Gilead look like buyers: analysts
Fierce Pharma
Mon, 06/28/21 - 11:54 am
Tags:
M&A, Joe Biden, Biogen, Gilead Sciences, oncology, gene therapy
Will Biogen’s new Alzheimer’s drug’s burden on Medicare be big, huge, or catastrophic?
Stat
Mon, 06/28/21 - 10:44 am
Tags:
Biogen, Aduhelm, FDA, Medicare, Alzheimer's disease
Biogen says it may adjust Aduhelm price if more patients take it than expected
Beckers Hospital Review
Fri, 06/25/21 - 11:00 am
Tags:
Biogen, Aduhelm, drug pricing, Alzheimer's disease
Warren, Cassidy want hearing on new Alzheimer's drug coverage
The Hill
Thu, 06/24/21 - 11:07 am
Tags:
Senate, Biogen, Aduhelm, Medicare, Alzheimer's disease, Bill Cassidy, Elizabeth Warren
Eisai-Biogen Alzheimer’s drug gets FDA breakthrough designation
Pharmaceutical Business Review
Thu, 06/24/21 - 10:56 am
Tags:
Eisai, Biogen, FDA, lecanemab, breakthrough status, Alzheimer's disease
FDA documents show how controversial Alzheimer's drug decision was reached
BioPharma Dive
Tue, 06/22/21 - 10:50 pm
Tags:
Biogen, Aduhelm, FDA, Alzheimer's disease
Woodcock defends Biogen's new Alzheimer's drug, says it has more supportive data than many past accelerated approvals
Endpoints
Tue, 06/22/21 - 10:34 pm
Tags:
FDA, Janet Woodcock, Biogen, Aduhelm, Alzheimer's disease
Biogen's new Alzheimer's drug serves as a rallying cry for drug pricing reforms
Endpoints
Tue, 06/22/21 - 11:14 am
Tags:
EmployersRx, Biogen, Alzheimer's disease, drug pricing
Biogen (BIIB) Initiates Late-Stage Study on Lupus Candidate
Yahoo/Zacks.com
Mon, 06/21/21 - 10:54 am
Tags:
Biogen, lupus, clinical trials, BIIB059
'This is not a shotgun approach to dementia': Hospital execs share how they're rolling out Aduhelm
Beckers Hospital Review
Fri, 06/18/21 - 10:09 am
Tags:
Biogen, Aduhelm, hospitals, Alzheimer's disease
First patient receives controversial Biogen Alzheimer's drug
NASDAQ
Wed, 06/16/21 - 11:40 pm
Tags:
Biogen, Aduhelm, Alzheimer's disease
Biogen's other Alzheimer's drug fails in late-stage trial
Bizjournals
Wed, 06/16/21 - 11:26 pm
Tags:
Biogen, Alzheimer's disease, clinical trials, gosuranemab
Public Citizen demands removal of top FDA officials over Biogen Alzheimer's approval
Seeking Alpha
Wed, 06/16/21 - 11:58 am
Tags:
Biogen, FDA, Public Citizen, Aduhelm, Alzheimer's disease, Janet Woodcock
Despite controversy, Biogen's Aduhelm is already generating enthusiasm among doctors: survey
Fierce Pharma
Tue, 06/15/21 - 11:43 am
Tags:
Biogen, Aduhelm, physicians, Alzheimer's disease
These 3 Words From the FDA Ensure the Biogen Drama Is Far From Over
Motley Fool
Tue, 06/15/21 - 10:39 am
Tags:
FDA, Biogen, Aduhelm, accelerated approvals, Alzheimer's disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.